Martin Lambert
Known title: DirectorCIK: 0001198824
Associated companies
Transaction History
| CVEO | ▲ Buy | Grant | 3,624 | $0 | 5/27/2026 | View on chart |
| CVEO | ▲ Buy | Grant | 6,021 | $0 | 5/14/2025 | View on chart |
| CVEO | ▲ Buy | Grant | 5,051 | $0 | 5/15/2024 | View on chart |
| CVEO | ▲ Buy | Grant | 5,947 | $0 | 5/17/2023 | View on chart |
| CVEO | ▼ Sell | Open Market | 10,665 | $336K | 11/8/2022 | View on chart |
| CVEO | ▼ Sell | Open Market | 10,348 | $321K | 11/2/2022 | View on chart |
| CVEO | ▼ Sell | Open Market | 5,813 | $180K | 11/2/2022 | View on chart |
| CVEO | ▼ Sell | Open Market | 9,187 | $285K | 11/1/2022 | View on chart |
| CVEO | ▼ Sell | Open Market | 10,000 | $312K | 10/31/2022 | View on chart |
| CVEO | ▲ Buy | Grant | 4,879 | $0 | 5/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Civeo (CVEO) receives new analyst coverage and price targets
Roth Capital began coverage of Civeo and issued a $39 price target. Northland Capital also started coverage, assigning an Outperform rating and a $42 target. Both firms' reports add fresh analyst attention to the stock. The targets sit above the recent 52‑week high of $36.50, suggesting expectations of further upside.
Civeo (CVEO) receives new analyst coverage and price targets. Roth Capital began coverage of Civeo and issued a $39 price target. Northland Capital also started coverage, assigning an Outperform rating and a $42 target. Both firms' reports add fresh analyst attention to the stock. The targets sit above the recent 52‑week high of $36.50, suggesting expectations of further upside.